BMC Cardiovascular Disorders (Aug 2005)

Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques

  • Fagerberg Björn,
  • Thelle Dag S,
  • Mattsson-Hulten Lillemor,
  • Stemme Veronika,
  • Ohlsson Bertil G,
  • Hägg Daniel A,
  • Snäckestrand Magnus SC,
  • Englund Mikael CO,
  • Svensson Per-Arne,
  • Wiklund Olov,
  • Carlsson Lena MS,
  • Carlsson Björn

DOI
https://doi.org/10.1186/1471-2261-5-25
Journal volume & issue
Vol. 5, no. 1
p. 25

Abstract

Read online

Abstract Background The protective role of high-density lipoprotein (HDL) in the cardiovascular system is related to its role in the reverse transport of cholesterol from the arterial wall to the liver for subsequent excretion via the bile. Scavenger receptor class B type I (SR-BI) binds HDL and mediates selective uptake of cholesterol ester and cellular efflux of cholesterol to HDL. The role of SR-BI in atherosclerosis has been well established in murine models but it remains unclear whether SR-BI plays an equally important role in atherosclerosis in humans. The aim of this study was to investigate the expression of SR-BI and its isoforms in human macrophages and atherosclerotic plaques. Methods The effect of hypoxia and minimally modified low-density lipoprotein (mmLDL), two proatherogenic stimuli, on SR-BI expression was studied in human monocyte-derived macrophages from healthy subjects using real-time PCR. In addition, SR-BI expression was determined in macrophages obtained from subjects with atherosclerosis (n = 15) and healthy controls (n = 15). Expression of SR-BI isoforms was characterized in human atherosclerotic plaques and macrophages using RT-PCR and DNA sequencing. Results SR-BI expression was decreased in macrophages after hypoxia (p Conclusion We conclude that SR-BI is regulated by proatherogenic stimuli in humans. However, we found no differences between subjects with atherosclerosis and healthy controls. This indicates that altered SR-BI expression is not a common cause of atherosclerosis. In addition, we identified SR-BIII as a novel isoform expressed in human macrophages and in human atherosclerotic plaques.